INSIGHTS ON PHARMACEUTICAL PACKAGING

• Nebulizers: Package Integrity Testing Challenges And Solutions

  Maintaining sterile packaging for nebulizer drugs is vital to prevent contamination. Learn how regulatory standards and advanced leak detection methods address integrity challenges in high-risk formats.

• The Enhanced Version Of Ready-To-Use Vial Platform

  Discover a platform for aseptic manufacturing that offers pre-sterilized vials for biologics to improve efficiency and safety with automated filling systems and advanced packaging for optimized drug containment.

• Which X-Ray, Metal Detector, Or Checkweigher Is Right For Your Industry?

  Navigate the complexities of pharmaceutical safety with a guide to tailored inspection systems. Match the right technology to your specific product format for total compliance and quality.

• Secondary Packaging: Cartoning And Kitting

  Fast deployment, scalable production, and rigorous quality control enabled the delivery of over 20 million complex kits in eight months, demonstrating how efficient operations can meet urgent demand.

• Achieving EU GMP Annex 1 Compliance For Contamination Control

  3/4/2025

  Gain insight into three areas that have been key in ensuring a robust contamination control strategy to help ensure compliance with the updated Annex 1 regulation: planning, people, and products.

• Solving The Challenges Of Transdermal Patch Package Integrity

  1/5/2026

  Ensuring transdermal patch packaging integrity is critical for safety and efficacy. See how advanced methods deliver precise, reliable leak detection, outperforming traditional approaches.

• Establishing A Container Closure System — Engineering For Integrity

  8/31/2026

  CCS design in aseptic manufacturing involves more than component selection. This article examines how elastomeric closures, barrier configurations, component formats, and plunger placement affect integrity and line performance.

• The Fill/Finish Timeline: What Comes After Manufacturing

  6/15/2026

  The post-manufacturing backend of sterile injectable fill-finish operates in a strict sequence—encompassing inspection, testing, QA review, and complex labeling validation—requiring early planning to avoid timeline delays.

• Cutting Through Complexity: An Integrated Model For Faster PFS Development

  4/7/2026

  Discover how integrated, end-to-end development for prefilled syringes can streamline timelines, enhance patient-centric delivery, and scale efficiently from early development to global launch.